Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $622.8150 (2%) ($622.8150 - $622.8150) on Mon. Nov. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.92% (three month average) | RSI | 76 | Latest Price | $622.8150(2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 5.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) XLV(40%) DIA(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.96% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.96% (StdDev 1.92%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $634.13(-1.78%) | 10 Day Moving Average | $626.01(-0.51%) | 20 Day Moving Average | $593.68(4.91%) | To recent high | -9% | To recent low | 14.7% | Market Cap | $66.036b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |